|
Diagnostic Clinical Trials
IBI is dedicated to improving the lives of patients through its innovative diagnostic products. The goal of the diagnostic program is to develop products that will enable rapid detection, and earlier intervention. Our current clinical trial is directed toward patients colonized with Methicillin Resistant Staphylococcue aureus (MRSA).
For Patients:
One of the most important steps in the product development process is the clinical trials, in which patients volunteer to receive non FDA approved diagnostic tests to see if they perform as well as approved FDA diagnostic tests for a specific condition.
More information on health, infectious disease, cardiovascular disease and their management can be found at the websites of these organizations:
Infectious Disease Society of America
National Foundation for Infectious Disease
MEDscape
National Institute of Allergy and Infectious Disease
American Heart Institute
Cardiovascular Disease Foundation
National Heart Lung & Blood Institute
For Physicians:
To have your name added to our e-mail list and to receive additional information, please email us at physicians@innovativebiosensors.com